<SEC-DOCUMENT>0000950170-22-018607-index.html : 20220916 <SEC-HEADER>0000950170-22-018607.hdr.sgml : 20220916 <ACCEPTANCE-DATETIME>20220916161339 ACCESSION NUMBER: 0000950170-22-018607 CONFORMED SUBMISSION TYPE: PRE 14A PUBLIC DOCUMENT COUNT: 6 CONFORMED PERIOD OF REPORT: 20221110 FILED AS OF DATE: 20220916 DATE AS OF CHANGE: 20220916 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EyePoint Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001314102 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 262774444 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: PRE 14A SEC ACT: 1934 Act SEC FILE NUMBER: 000-51122 FILM NUMBER: 221248202 BUSINESS ADDRESS: STREET 1: 480 PLEASANT STREET STREET 2: SUITE B300 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617-926-5000 MAIL ADDRESS: STREET 1: 480 PLEASANT STREET STREET 2: SUITE B300 CITY: WATERTOWN STATE: MA ZIP: 02472 FORMER COMPANY: FORMER CONFORMED NAME: pSivida Corp. DATE OF NAME CHANGE: 20080619 FORMER COMPANY: FORMER CONFORMED NAME: pSivida LTD DATE OF NAME CHANGE: 20050111 </SEC-HEADER> <DOCUMENT> <TYPE>PRE 14A <SEQUENCE>1 <FILENAME>eypt_pre_14a_09-16-2022.htm <DESCRIPTION>PRE 14A <TEXT> Document 1 - file: eypt_pre_14a_09-16-2022.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>2 <FILENAME>img55613222_0.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 2 - file: img55613222_0.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>img55613222_1.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 3 - file: img55613222_1.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>img55613222_2.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: img55613222_2.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>img55613222_3.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: img55613222_3.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>img55613222_4.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: img55613222_4.jpg
</DOCUMENT> </SEC-DOCUMENT>